Exploring HSP90α and hs-CRP using AI models to predict prognosis in advanced hepatocellular carcinoma treated with PD-1 inhibitors and targeted therapy.

Saved in:
Bibliographic Details
Title: Exploring HSP90α and hs-CRP using AI models to predict prognosis in advanced hepatocellular carcinoma treated with PD-1 inhibitors and targeted therapy.
Authors: Wu ZY; Department of Medical Administration, Panzhihua Central Hospital, Panzhihua, Sichuan, China., Li X; Department of Oncology, 363 Hospital, Chengdu, China., Yang L; Department of Oncology, Chongqing General Hospital, Chongqing University, Chongqing, China., Shi Y; Department of Oncology, 363 Hospital, Chengdu, China., Liu X; Department of Oncology, 363 Hospital, Chengdu, China., Wen L; Department of Geriatric Cardiology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China., Song Y; Department of Radiotherapy, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China., Du W; Department of Pharmacy, Southwest Medical University, Luzhou, China., Tu Y; Department of Ophthalmic Optics, Southwest Medical University, Luzhou, China., Wei Q; Department of Medical Imaging, Southwest Medical University, Luzhou, China., Liu J; Basic Medicine College, Panzhihua University, Panzhihua, China., Li H; Department of Anesthesiology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.; Luzhou Key Laboratory of Research for Integrative on Pain and Perioperative Organ Protection, Luzhou, China., Wang P; Clinical Skills Center, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2025 Dec 12; Vol. 16, pp. 1726967. Date of Electronic Publication: 2025 Dec 12 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1663-9812
DOI:10.3389/fphar.2025.1726967